Selected research
Industry Research
Therapeutic Protein Industry Research Report 2026
Market perspective
The global Therapeutic Protein market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Therapeutic Protein is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Therapeutic Protein is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Therapeutic Protein is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Therapeutic Protein include Eli Lilly, Baxter International, Amgen, AstraZeneca, GeneScience Pharmaceuticals, Generex Biotechnology, Genentech, Diasome Pharmaceuticals and Chugai Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Therapeutic Protein market in terms of revenue (US$ million) and, where applicable, sales volume (k tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Therapeutic Protein Market by Company
Eli Lilly
Baxter International
Amgen
AstraZeneca
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech
Diasome Pharmaceuticals
Chugai Pharmaceutical
Boehringer Ingelheim
Abbott Laboratories
Therapeutic Protein Segment by Type
Insulin
Human Growth Hormone
Blood Clotting Factors
Interferon
Monoclonal Antibodies
Follicle Stimulating Hormone
Erythropoietin
Therapeutic Protein Segment by Application
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes
Therapeutic Protein Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Therapeutic Protein market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Therapeutic Protein and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Therapeutic Protein.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Therapeutic Protein by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Therapeutic Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Insulin
- Human Growth Hormone
- Blood Clotting Factors
- Interferon
- Monoclonal Antibodies
- Follicle Stimulating Hormone
- Erythropoietin
Applications
- Pharmaceutical Companies
- Healthcare Service Providers
- Research Organizations
- Academic Research Institutes
Companies covered
- Eli Lilly
- Baxter International
- Amgen
- AstraZeneca
- GeneScience Pharmaceuticals
- Generex Biotechnology
- Genentech
- Diasome Pharmaceuticals
- Chugai Pharmaceutical
- Boehringer Ingelheim
- Abbott Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Therapeutic Protein Market Size (2021-2032)
- 2.2.2 Global Therapeutic Protein Sales (2021-2032)
- 2.2.3 Global Therapeutic Protein Market Average Price (2021-2032)
- 2.3 Therapeutic Protein by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Insulin
- 2.3.3 Human Growth Hormone
- 2.3.4 Blood Clotting Factors
- 2.3.5 Interferon
- 2.3.6 Monoclonal Antibodies
- 2.3.7 Follicle Stimulating Hormone
- 2.3.8 Erythropoietin
- 2.4 Therapeutic Protein by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pharmaceutical Companies
- 2.4.3 Healthcare Service Providers
- 2.4.4 Research Organizations
- 2.4.5 Academic Research Institutes
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Therapeutic Protein Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Therapeutic Protein Sales (k tons) of Manufacturers (2021-2026)
- 3.3 Global Therapeutic Protein Revenue of Manufacturers (2021-2026)
- 3.4 Global Therapeutic Protein Average Price by Manufacturers (2021-2026)
- 3.5 Global Therapeutic Protein Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Therapeutic Protein, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Therapeutic Protein, Product Type & Application
- 3.8 Global Manufacturers of Therapeutic Protein, Established Date
- 3.9 Global Therapeutic Protein Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Eli Lilly
- 4.1.1 Eli Lilly Company Information
- 4.1.2 Eli Lilly Business Overview
- 4.1.3 Eli Lilly Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Eli Lilly Therapeutic Protein Product Portfolio
- 4.1.5 Eli Lilly Recent Developments
- 4.2 Baxter International
- 4.2.1 Baxter International Company Information
- 4.2.2 Baxter International Business Overview
- 4.2.3 Baxter International Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Baxter International Therapeutic Protein Product Portfolio
- 4.2.5 Baxter International Recent Developments
- 4.3 Amgen
- 4.3.1 Amgen Company Information
- 4.3.2 Amgen Business Overview
- 4.3.3 Amgen Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Amgen Therapeutic Protein Product Portfolio
- 4.3.5 Amgen Recent Developments
- 4.4 AstraZeneca
- 4.4.1 AstraZeneca Company Information
- 4.4.2 AstraZeneca Business Overview
- 4.4.3 AstraZeneca Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 AstraZeneca Therapeutic Protein Product Portfolio
- 4.4.5 AstraZeneca Recent Developments
- 4.5 GeneScience Pharmaceuticals
- 4.5.1 GeneScience Pharmaceuticals Company Information
- 4.5.2 GeneScience Pharmaceuticals Business Overview
- 4.5.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 GeneScience Pharmaceuticals Therapeutic Protein Product Portfolio
- 4.5.5 GeneScience Pharmaceuticals Recent Developments
- 4.6 Generex Biotechnology
- 4.6.1 Generex Biotechnology Company Information
- 4.6.2 Generex Biotechnology Business Overview
- 4.6.3 Generex Biotechnology Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Generex Biotechnology Therapeutic Protein Product Portfolio
- 4.6.5 Generex Biotechnology Recent Developments
- 4.7 Genentech
- 4.7.1 Genentech Company Information
- 4.7.2 Genentech Business Overview
- 4.7.3 Genentech Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Genentech Therapeutic Protein Product Portfolio
- 4.7.5 Genentech Recent Developments
- 4.8 Diasome Pharmaceuticals
- 4.8.1 Diasome Pharmaceuticals Company Information
- 4.8.2 Diasome Pharmaceuticals Business Overview
- 4.8.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Diasome Pharmaceuticals Therapeutic Protein Product Portfolio
- 4.8.5 Diasome Pharmaceuticals Recent Developments
- 4.9 Chugai Pharmaceutical
- 4.9.1 Chugai Pharmaceutical Company Information
- 4.9.2 Chugai Pharmaceutical Business Overview
- 4.9.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Chugai Pharmaceutical Therapeutic Protein Product Portfolio
- 4.9.5 Chugai Pharmaceutical Recent Developments
- 4.10 Boehringer Ingelheim
- 4.10.1 Boehringer Ingelheim Company Information
- 4.10.2 Boehringer Ingelheim Business Overview
- 4.10.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Boehringer Ingelheim Therapeutic Protein Product Portfolio
- 4.10.5 Boehringer Ingelheim Recent Developments
- 4.11 Abbott Laboratories
- 4.11.1 Abbott Laboratories Company Information
- 4.11.2 Abbott Laboratories Business Overview
- 4.11.3 Abbott Laboratories Therapeutic Protein Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Abbott Laboratories Therapeutic Protein Product Portfolio
- 4.11.5 Abbott Laboratories Recent Developments
5 Global Therapeutic Protein Market Scenario by Region
- 5.1 Global Therapeutic Protein Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Therapeutic Protein Sales by Region: 2021-2032
- 5.2.1 Global Therapeutic Protein Sales by Region: 2021-2026
- 5.2.2 Global Therapeutic Protein Sales by Region: 2027-2032
- 5.3 Global Therapeutic Protein Revenue by Region: 2021-2032
- 5.3.1 Global Therapeutic Protein Revenue by Region: 2021-2026
- 5.3.2 Global Therapeutic Protein Revenue by Region: 2027-2032
- 5.4 North America Therapeutic Protein Market Facts & Figures by Country
- 5.4.1 North America Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Therapeutic Protein Sales by Country (2021-2032)
- 5.4.3 North America Therapeutic Protein Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Therapeutic Protein Market Facts & Figures by Country
- 5.5.1 Europe Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Therapeutic Protein Sales by Country (2021-2032)
- 5.5.3 Europe Therapeutic Protein Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Therapeutic Protein Market Facts & Figures by Country
- 5.6.1 Asia Pacific Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Therapeutic Protein Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Therapeutic Protein Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Therapeutic Protein Market Facts & Figures by Country
- 5.7.1 South America Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Therapeutic Protein Sales by Country (2021-2032)
- 5.7.3 South America Therapeutic Protein Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.7.7 Colombia
- 5.8 Middle East and Africa Therapeutic Protein Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Therapeutic Protein Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Therapeutic Protein Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Therapeutic Protein Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Therapeutic Protein Sales by Type (2021-2032)
- 6.1.1 Global Therapeutic Protein Sales by Type (2021-2032) & (k tons)
- 6.1.2 Global Therapeutic Protein Sales Market Share by Type (2021-2032)
- 6.2 Global Therapeutic Protein Revenue by Type (2021-2032)
- 6.2.1 Global Therapeutic Protein Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Therapeutic Protein Revenue Market Share by Type (2021-2032)
- 6.3 Global Therapeutic Protein Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Therapeutic Protein Sales by Application (2021-2032)
- 7.1.1 Global Therapeutic Protein Sales by Application (2021-2032) & (k tons)
- 7.1.2 Global Therapeutic Protein Sales Market Share by Application (2021-2032)
- 7.2 Global Therapeutic Protein Revenue by Application (2021-2032)
- 7.2.1 Global Therapeutic Protein Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Therapeutic Protein Revenue Market Share by Application (2021-2032)
- 7.3 Global Therapeutic Protein Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Therapeutic Protein Value Chain Analysis
- 8.1.1 Therapeutic Protein Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Therapeutic Protein Production Mode & Process
- 8.2 Therapeutic Protein Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Therapeutic Protein Distributors
- 8.2.3 Therapeutic Protein Customers
9 Global Therapeutic Protein Analyzing Market Dynamics
- 9.1 Therapeutic Protein Industry Trends
- 9.2 Therapeutic Protein Industry Drivers
- 9.3 Therapeutic Protein Industry Opportunities and Challenges
- 9.4 Therapeutic Protein Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst